The results indicated that iEXO-OXA promoted the polarization of M2 phenotype to M1 phenotype upon disrupting the combination of galectin-9 and dectin 1, and TME was reprogrammed, increasing anti-tumor immunity for pancreatic cancer. Here, LGALS9 is linked to neoplasm.